Søgeresultater - Jean‐Pierre Armand

  • Showing 1 - 10 results of 10
Refine Results
  1. 1
    Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy

    Epidermal Growth Factor Receptor Tyrosine Kinase as a Target for Anticancer Therapy af Eric Raymond, Sandrine Faivre, Jean Pierre Armand

    Udgivet 2000
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  2. 2
    An Electrophysiological Study of the Postnatal Development of the Corticospinal System in the Macaque Monkey

    An Electrophysiological Study of the Postnatal Development of the Corticospinal System in the Macaque Monkey af Etienne Olivier, S. A. Edgley, Jean Pierre Armand, Roger Lemon

    Udgivet 1997
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  3. 3
    Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity

    Intestinal bacterial β-glucuronidase as a possible predictive biomarker of irinotecan-induced diarrhea severity af Ali N. Chamseddine, Michel Ducreux, Jean‐Pierre Armand, Xavier Paolettí, Tuvana Satar, Angélo Paci, Olivier Mir

    Udgivet 2019
    Få fuldtekst Få fuldtekst
    Revisão
    Føj til favoritter
    Saved in:
  4. 4
    Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin

    Treatment of advanced squamous cell carcinoma of the skin with cisplatin, 5-fluorouracil, and bleomycin af Hussein Sadek, N. Azli, J. L. Wendling, Esteban Cvitkovic, Mohamed Rahal, G. Mamelle, J. C. Guillaume, Jean Pierre Armand, Marie France Avril

    Udgivet 1990
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  5. 5
    Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer

    Safety and Pharmacokinetics of Escalated Doses of Weekly Intravenous Infusion of CCI-779, a Novel mTOR Inhibitor, in Patients With Cancer af Éric Raymond, Jérôme Alexandre, Sandrine Faivre, Karina Vera, Eric Materman, Joseph Boni, Cathie Leister, Joan Korth‐Bradley, Axel R. Hanauske, Jean‐Pierre Armand

    Udgivet 2004
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  6. 6
    Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

    Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials af G G Chabot, D Abigerges, G. Catimel, Stéphane Culine, M Forni, Jean Marc Extra, M. Mahjoubi, Patrice Herait, Jean‐Pierre Armand, R. Bugat

    Udgivet 1995
    Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  7. 7
    Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma

    Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma af Éric Raymond, Michel Fabbro, Valérie Boige, Olivier Rixe, Marc Frénay, Gilles Vassal, Sandrine Faivre, Evelyne Sicard, Caroline Germa, J.M. Rodier, Laurent Vernillet, Jean‐Pierre Armand

    Udgivet 2003
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  8. 8
    Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies

    Phase I and Pharmacokinetic Study of Aplidine, a New Marine Cyclodepsipeptide in Patients With Advanced Malignancies af Sandrine Faivre, Stéphanie Chièze, Catherine Delbaldo, Nora Ady-vago, Cecilia Guzmán, Luis López Lázaro, Stéphanie Lozahic, José Jimeno, Fernando Pico, Jean Pierre Armand, José A. López-Martín, Éric Raymond

    Udgivet 2005
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  9. 9
    Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer

    Safety, Pharmacokinetic, and Antitumor Activity of SU11248, a Novel Oral Multitarget Tyrosine Kinase Inhibitor, in Patients With Cancer af Sandrine Faivre, Catherine Delbaldo, Karina Vera, Caroline Robert, Stéphanie Lozahic, Nathalie Lassau, Carlo L. Bello, Samuel E. DePrimo, Nicoletta Brega, Giorgio Massimini, Jean‐Pierre Armand, P. Scigalla, Éric Raymond

    Udgivet 2005
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:
  10. 10
    A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib

    A Novel Epidermal Growth Factor Receptor Inhibitor Promotes Apoptosis in Non–Small Cell Lung Cancer Cells Resistant to Erlotinib af Thibault De La Motte Rouge, Lorenzo Galluzzi, Ken A. Olaussen, Yaël Zermati, Ezgi Tasdemir, Thomas Robert, Hugues Ripoche, Vladimir Lazar, Philippe Dessen, Francis Harper, Gérard Pierron, Guillaume Pinna, Natália de Souza Araujo, Annick Harel-Belan, Jean‐Pierre Armand, Tai W. Wong, Jean Charles Soria, Guido Kroemer

    Udgivet 2007
    Få fuldtekst Få fuldtekst
    Artigo
    Føj til favoritter
    Saved in:

Søgeredskaber: